Stock Market & Financial Investment News

News Breaks January 7, 2013 14:02 EDT ACOR Acorda Therapeutics sees FY13 R&D $60M-$70M, SG&A $170M-$180M News For ACOR From The Last 14 Days Check below for free stories on ACOR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 07:12 EDT ACOR Acorda Therapeutics says issued additional U.S. patent for AMPYRA Subscribe for More Information May 9, 2013 10:11 EDT ACOR Acorda Therapeutics has a conference call hosted by JPMorgan Subscribe for More Information 07:05 EDT ACOR Acorda says data support initiation of current dalfampridine development program Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.